Concepedia

Yoji Nagira

YN

Statistics

Publications

3

Citations

74

H-Index

3

Active since

2023

Affiliations

The University of Osaka(Current)

Shionogi (Japan)

Futaba (Japan)

Yoji Nagira is an author at The University of Osaka specializing in cancer immunology, cd8+ tumor-infiltrating lymphocytes, and immunotherapy.

ORCID

Publications per year

2023–2024

3

Publications

3

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells

Yoji Nagira, Morio Nagira, Ryohei Nagai et al. · Molecular Cancer Therapeutics · 2023 · 32 citations · Full text

, , +17

Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile

Azumi Ueyama, Wataru Nogami, Kunitaka Nashiki et al. · The Journal of Immunology · 2023 · 31 citations

, , +17

In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications

Yoshinori Hayashi, Azumi Ueyama, Soichiro Funaki et al. · BMC Cancer · 2024 · 11 citations · Full text

, , +17

1–3 of 3